2 A. Guglielmotti, A. C. De Joannon, N. Cazzolla, M. Marchetti, L. Soldo,
G. Cavallo and M. Pinza, Pharmacol. Res., 1995, 32, 369.
3 M. Hartmann, M. E. Sommer, B. K. Keppler, F. Kratz and Th.
J. Einhaüser, J. Inorg. Biochem., 1995, 59, 214; M. J. Clarke, Coord.
Chem. Rev., 2003, 236, 209.
4 J.-H. Sun, C. A. Teleha, J.-S. Yan, J. D. Rodgers and D. A. Nugiel,
J. Org. Chem., 1997, 62, 5627.
5 For a recent review, see: E. S. Hsu, Am. J. Ther., 2010, 17, 476.
6 For a review, see: S. Di Cosimo, G. Ferretti, P. Papaldo, P. Carlini,
A. Fabi and F. Cognetti, Drugs Today, 2003, 39, 157.
7 A. P. Krapcho and S. N. Haydar, J. Heterocycl. Chem., 2001, 38, 1153;
E. C. Dees, L. R. Whitfield, W. R. Grove, S. Rummel, L. B. Grochow
and R. C. Donehower, Clin. Cancer Res., 2000, 6, 3885.
8 For a review, see: A. Schmidt, A. Beutler and B. Snovydovych,
Eur. J. Org. Chem., 2008, 4073.
9 T. Jin and Y. Yamamoto, Angew. Chem., Int. Ed., 2007, 46, 3323; Z. Liu,
F. Shi, P. D. G. Martinez, C. Raminelli and R. C. Larock, J. Org. Chem.,
2008, 73, 219.
10 P. Li, J. Zhao, C. Wu, R. C. Larock and F. Shi, Org. Lett., 2011, 13,
3340.
0.75 mmol, 3 equiv.), di-tert-butyl dicarbonate (344 μL,
1.50 mmol, 6 equiv.) and 5 mL of acetonitrile in a 10 mL vial,
o-(trimethylsilyl)phenyl triflate (84 mg, 0.28 mmol, 1.1 equiv.)
was added. The vial was capped and the reaction mixture was
allowed to stir for 10 h at 65 °C. Then 3 mL of 1 M HCl was
added and the mixture was heated at 75 °C for an additional 3 h.
After cooling to room temperature, 25 mL of dichloromethane
was added to the residue, and the reaction mixture was poured
into 25 mL of water in a separatory funnel. After shaking the
layers, the organic fraction was separated and the aqueous layer
was extracted with dichloromethane (2 × 10 mL). All organic
fractions were combined and concentrated under reduced
pressure. The residue was purified by flash chromatography on
silica gel using hexanes–EtOAc as the eluent to afford the
desired indazole 15o as a colorless amorphous solid in an 81%
1
(method A: 80%): H NMR (400 MHz, CDCl3) δ 3.15 (dd, J =
11 N-Tosylhydrazones have been alternatively employed as starting materials
for the benzyne Fischer-indole reaction: D. McAusland, S. Seo,
D. G. Pintori, J. Finlayson and M. F. Greaney, Org. Lett., 2011, 13, 3667.
12 C. Spiretti, S. Keeling and J. E. Moses, Org. Lett., 2010, 12, 3368.
13 A. V. Dubrovskiy and R. C. Larock, Org. Lett., 2011, 13, 4136.
14 Y. Himeshima, T. Sonoda and H. Kobayashi, Chem. Lett., 1983, 1211.
15 During our optimization studies, we have investigated the first NCS-
chlorination step by conducting the reaction in CD3CN and monitoring
the completeness of the reaction by 1H NMR spectroscopy. We have
found that the hydrazone 6a was fully converted to the chlorohydrazone
7a in about 30 minutes. We have also found that upon addition of CsF to
the resulting reaction mixture, the chlorohydrazone 7a is instantly con-
verted to its fluoro analogue 7a′ (supported by HRMS).
16 For an explanation of the reactivity of the unsymmetrical monomethoxy
benzyne, see: Z. Liu and R. C. Larock, J. Org. Chem., 2006, 71, 3198;
R. Sanz, Org. Prep. Proced. Int., 2008, 40, 215; P. H.-Y. Cheong, R.
S. Paton, S. M. Bronner, G.-Y. J. Im, N. K. Garg and K. N. Houk, J. Am.
Chem. Soc., 2010, 132, 1267.
17 Supporting the mechanism outlined in Scheme 2, GC/MS analysis of the
crude reaction mixture for the preparation of 15a showed a peak (m/z =
113.1) corresponding to N-methylsuccinimide. Additionally, the absence
of a peak (m/z = 264.32) corresponding to the dimerization product of
compound 6a suggests that this reaction does not proceed through a
[3 + 2] cycloaddition of an azomethyneimine and an aryne.
18 D. Vina, E. del Olmo, J. L. López-Pérez and A. San Feliciano, Org. Lett.,
2007, 9, 525.
10.2, 6.2 Hz, 2H), 3.30 (dd, J = 10.1, 6.1 Hz, 2H), 4.04 (s, 3H),
7.12 (t, J = 7.6 Hz, 1H), 7.20–7.26 (m, 1H), 7.28–7.50 (m, 6H),
7.63 (d, J = 8.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 29.47,
35.36, 35.96, 109.04, 117.54, 119.81, 120.47, 122.81, 126.18,
126.35, 128.59, 140.98, 142.00, 144.80; MS (EI) m/z (%) 236
(M+, 58%), 145 (100%), 91 (21%); HRMS (EI) calcd for
[M + H]+ C16H17N2 237.1386, found 237.1393; IR (CH2Cl2,
cm−1) 2928 (s), 2859 (m), 1616 (s), 1505 (s).
Acknowledgements
We thank the National Science Foundation and the National
Institutes of Health Kansas University Center of Excellence in
Chemical Methodology and Library Development (P50
GM069663) for their generous financial support.
Notes and references
1 For a review, see: S. Brase, C. Gil and K. Knepper, Bioorg. Med. Chem.,
2002, 10, 2415.
2412 | Org. Biomol. Chem., 2012, 10, 2409–2412
This journal is © The Royal Society of Chemistry 2012